Abbott Labs: Growth Stock With an Attractive Yield
Most of the remaining 43 S&P 500 Dividend Aristocrats have strong finances and are worthy of consideration for value investors, especially those who want to upgrade dividend yields. For example, the stock of Abbott (ABT), long time Dividend Aristocrat, has been flattish over the last 10 years, mostly in the 40s & 50s. Friday it closed at $46.46 with a yield of 3.8%. However, that performance is not so bad when compared with Dow Jones Industrials and S&P 500 which are lower. ABT is a leading pharmaceutical company founded in 1888 and has a long track record of growth. From 2002 to 2009, sales doubled to $30 billion while basic EPS rose from $1.63 to $3.71. Dividends were increased from 94¢ to $1.60 and raised another 10% this year to an annual rate of $1.76.... Read more
Latest Price: $ 104.48
Dividend Yield (TTM): 2.41%
- 2026-01-15: $ 0.63
- 2026-04-15: $ 0.63
- 2026-07-15: $ 0.63
- 2026-10-15: $ 0.63
Older articles featuring ABT:
Abbott declares 411th consecutive quarterly dividendAbbott declares 410th consecutive quarterly dividend
Abbott declares 409th consecutive quarterly dividend
Abbott increases quarterly dividend for 54th consecutive year
Abbott Declares 407th Consecutive Quarterly Dividend
Abbott Declares 406th Consecutive Quarterly Dividend
November Buys: 3 Monthly Paying CEFs, Plus Some Dividend Growth Opportunities
Dividend Challenger Highlights: Week Of December 13
My Dividend Growth Portfolio November Review: 32 Holdings, 1 Buy
Dividend Challenger Highlights: Week Of November 8